2. • Silence or deregulate expression of a gene
• Different approaches
o Reverse genetics (limitations)
o Cre/Lox recombinase target systems
o RNA interference technique (without altering DNA
seq)
3. RNA Interference Based Therapeutics
• use of RNA to inhibit gene expression
• Most common approach
• May involve either of these two
o Small interfering RNA(siRNA)
o microRNA
Incorporated into RNA-induced silencing complex (RISC)
4.
5. Limitations
Small RNA degraded by nucleases
Cell membranes are impermeable to sRNA
Could induce inflammatory response
6. Solutions to overcome the limitations of siRNA
• Synthetic siRNA mimics the structure of Dicer cleavage
products
• involves covalent modification of the nucleotide structure
for promoting siRNA silencing effectiveness, enhancing
resistance to nucleases, reducing nonspecific ‘off-target’
effects, and blocking innate immune responses
8. siRNA conjugates and delivery vehicles
systemic delivery of the RNA in the micro or nanoparticles
attached to cholesterol groups or conjugated with antibodies
recognizing particular cell receptors.